Curaleaf Holdings CEO Joseph Lusardi is ecstatic about the company’s record-setting, $400 million USD equity raise and recent listing on the CSE. Curaleaf operates in the United States, is a fully vertical medical cannabis operator, and sells 90 percent of what the company cultivates and produces in its dispensaries. The company will be operating in 12 states by the end of 2018 and is licensed to open 69 dispensaries nation-wide. Curaleaf’s largest footprint is in Florida, where it already has a strong delivery presence and 13 dispensaries, with plans to open 22 more stores in the coming months. Lusardi supports the STATES Act because it would open up banking and debt markets to US cannabis companies.
Related Articles → See More
-
US (CA): Cannacruz relocates cultivation operations
-
“UK medical cannabis is maturing”
-
The future of supplemental lighting in the Netherlands: opportunities and rising costs
-
Synthetic seeds show a glimpse of the future for cannabis breeding
-
"Genetics increasingly seen as a core infrastructure element in regulated supply chains"
-
Research shows: movable screens boost potential crop yield by 25%
-
Seeds Here Now expands lineup with three breeders
-
"Thanks to DES, we can more easily dose more CO₂"
-
Not an average greenhouse at NC State University
-
Smart root zone monitoring in stone wool cultivation